C12N 9/1025
Acyltransferases
Official title: {Acyltransferases (2.3)}
C12N9/1025 (Acyltransferases) appears on 2,158 US grants and 3,063 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,158
- Published applications
- 3,063
- Assignees
- 1,168
- Inventors
- 6,122
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 8 | 0 |
| 1992 | 14 | 0 |
| 1993 | 13 | 0 |
| 1994 | 9 | 0 |
| 1995 | 14 | 0 |
| 1996 | 29 | 0 |
| 1997 | 31 | 0 |
| 1998 | 37 | 0 |
| 1999 | 34 | 0 |
| 2000 | 39 | 0 |
| 2001 | 45 | 7 |
| 2002 | 35 | 52 |
| 2003 | 40 | 102 |
| 2004 | 46 | 92 |
| 2005 | 31 | 66 |
| 2006 | 52 | 71 |
| 2007 | 71 | 58 |
| 2008 | 35 | 78 |
| 2009 | 54 | 105 |
| 2010 | 51 | 112 |
| 2011 | 67 | 101 |
| 2012 | 66 | 115 |
| 2013 | 81 | 121 |
| 2014 | 85 | 106 |
| 2015 | 110 | 139 |
| 2016 | 95 | 119 |
| 2017 | 76 | 144 |
| 2018 | 102 | 152 |
| 2019 | 115 | 158 |
| 2020 | 113 | 166 |
| 2021 | 112 | 128 |
| 2022 | 106 | 182 |
| 2023 | 75 | 188 |
| 2024 | 98 | 193 |
| 2025 | 91 | 186 |
| 2026 | 61 | 122 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for genetically-encoded high voltage-activated calcium channel blockers using engineered ubiquitin ligases6 Oct 2026US 12,753,228 B2The Trustees of Columbia University in the City of New York
- O-acetyl homoserine-producing microorganism and method for producing o-acetyl homoserine or l-methionine using same6 Oct 2026US 12,753,382 B2Cj Cheiljedang Corporation
- Expression of nitrogenase polypeptides in plant cells29 Sep 2026US 12,747,428 B2Commonwealth Scientific and Industrial Research Organisation
- Modified UBE3A gene for a gene therapy approach for Angelman syndrome15 Sep 2026US 12,734,250 B2University of South Florida
- Immobilized proteases for activation of the zymogen form of transglutaminase25 Aug 2026US 12,716,059 B2Curie Co. Inc.
- Metabolic switches for anti-tumor immunity8 Oct 2026US 2026/0308516 A1Cold Spring Harbor Laboratory
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- Method of producing curcuminoids8 Oct 2026US 2026/0308606 A1Nicoventures Trading Limited
- Compositions, systems and methods for programming immune cell function through targeted gene regulation1 Oct 2026US 2026/0297545 A1Duke University
- Biotechnological production of acetone1 Oct 2026US 2026/0297634 A1Evonik Operations GmbH
Most cited
By later US patents
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Chimeric gene comprising the arabidopsis histone H4 promoter for the transformation of plants765US 5,491,288 ARhone-Poulenc Agrochimie · 1996
- Chimeric gene for the transformation of plants655US 5,792,930 ARhone-Poulenc Agrochimie · 1998
- Generation of antibodies through lipid mediated DNA delivery427US 5,703,055 AVical Incorporated · 1997